Firms

Lifeforce Capital

Lifeforce Capital

Chevy Chase, Maryland, United States

lifeforcecap.comadviserinfo.sec.gov

LifeForce Capital is a healthcare venture-capital manager investing in software businesses that reshape care delivery and in software-first technology platforms for therapeutic development. Its own portfolio includes AI-enabled discovery, clinical software, precision neuroscience and technology-assisted care. The legal adviser is LifeForce Capital Management LLC, CRD 282550 and SEC file 802-118500, an exempt reporting adviser; that status does not imply SEC registration or endorsement. Its March 18, 2026 filing identifies John Kenneth Noonan as managing director and owner and lists a Chevy Chase, Maryland principal office, alongside historical San Francisco affiliations. The public roster is scoped to six named affiliates supported by the adviser filing, issuer disclosures and their own published biographies. Adam Pelavin co-leads AI-plus-health and neuroscience strategies; Jamie Daves publishes a venture-partner affiliation and co-founded the Neurorights Foundation. Sander Duncan and Rishi Sikka have dated or explicitly historical LifeForce roles. Nathan Bays is a FINRA-disclosed part-time venture advisor. The manager does not publish a complete accessible current staff directory, so these records are not represented as its entire current payroll. Sixteen exact legal private-fund vehicles are disclosed in the 2026 adviser filing. Their existence and management relationship do not establish new cash closings. Initial Fund I and II filings reported no securities sold against fundraising targets, which are not recorded as capital raised. Underlying fund or SPV allocations are not inferred from portfolio brand mentions. Synapticure’s February 2022 launch describes an actual USD 6M seed closed in early fall 2021 with LifeForce participating; that issuer participation is maintained separately from personal advisers and other corporate entities.

Founded
—
Type
Venture capital

Funds16

  • LIFEFORCE 1 LIFE HEALTHCARE SECONDARY, LLC—

    Exact legal private fund vehicle disclosed in LifeForce Capital Management LLC’s March18,2026 FormADV, private fund identifier 805-8487551789. Disclosure establishes the vehicle and adviser relationship, not a newly closed fundraising event. Actual closed capital, capital called/paid and exact closing day are unverified; amount and announcedAt intentionally unspecified.

  • LIFEFORCE CAPITAL FUND I, L.P.—

    Exact legal private fund vehicle disclosed in LifeForce Capital Management LLC’s March18,2026 FormADV, private fund identifier 805-7918706591. Disclosure establishes the vehicle and adviser relationship, not a newly closed fundraising event. Actual closed capital, capital called/paid and exact closing day are unverified; amount and announcedAt intentionally unspecified.

  • LIFEFORCE CAPITAL FUND II, L.P.—

    Exact legal private fund vehicle disclosed in LifeForce Capital Management LLC’s March18,2026 FormADV, private fund identifier 805-3033674029. Disclosure establishes the vehicle and adviser relationship, not a newly closed fundraising event. Actual closed capital, capital called/paid and exact closing day are unverified; amount and announcedAt intentionally unspecified.

  • LIFEFORCE CAPITAL IVY, LLC—

    Exact legal private fund vehicle disclosed in LifeForce Capital Management LLC’s March18,2026 FormADV, private fund identifier 805-7491987007. Disclosure establishes the vehicle and adviser relationship, not a newly closed fundraising event. Actual closed capital, capital called/paid and exact closing day are unverified; amount and announcedAt intentionally unspecified.

  • LIFEFORCE CAPITAL OPPORTUNITY FUND, L.P.—

    Exact legal private fund vehicle disclosed in LifeForce Capital Management LLC’s March18,2026 FormADV, private fund identifier 805-5388363468. Disclosure establishes the vehicle and adviser relationship, not a newly closed fundraising event. Actual closed capital, capital called/paid and exact closing day are unverified; amount and announcedAt intentionally unspecified.

  • LIFEFORCE CAPITAL, LLC—

    Exact legal private fund vehicle disclosed in LifeForce Capital Management LLC’s March18,2026 FormADV, private fund identifier 805-8241116753. Disclosure establishes the vehicle and adviser relationship, not a newly closed fundraising event. Actual closed capital, capital called/paid and exact closing day are unverified; amount and announcedAt intentionally unspecified.

  • LIFEFORCE CC, LLC—

    Exact legal private fund vehicle disclosed in LifeForce Capital Management LLC’s March18,2026 FormADV, private fund identifier 805-4102806862. Disclosure establishes the vehicle and adviser relationship, not a newly closed fundraising event. Actual closed capital, capital called/paid and exact closing day are unverified; amount and announcedAt intentionally unspecified.

  • LIFEFORCE LIFECYCLE I, LLC—

    Exact legal private fund vehicle disclosed in LifeForce Capital Management LLC’s March18,2026 FormADV, private fund identifier 805-5152360173. Disclosure establishes the vehicle and adviser relationship, not a newly closed fundraising event. Actual closed capital, capital called/paid and exact closing day are unverified; amount and announcedAt intentionally unspecified.

Team

Operations and support

Adam PelavinAdam PelavinPartner — AI, health and neuroscience
Jamie DavesJamie DavesVenture partner
John Kenneth NoonanJohn Kenneth NoonanManaging director and owner
Nathan BaysNathan BaysVenture advisor (part-time;FINRA-disclosed)
Rishi SikkaRishi SikkaVenture partner (historical;2022–2023 published affiliation)
Sander DuncanSander DuncanGeneral partner (historical;2020 fund disclosure)

Co-investing

ARCH Venture Partners
Y Combinator
S32
Kite, a Gilead Company
Altitude Life Science Ventures

Investments

$6M2022-02-01SynapticureGV, Y Combinator, Ron Conway, Martin Ventures, Byers Capital, Lifeforce Capital, David Hodgson, Joe Kraus, Jeff Huber, Adam M. Koppel, Gary Bisbee, Rohan Seth, Ben Silbermann, Divya Silbermann
$115M2025-11-20Aspen NeuroscienceARCH Venture Partners, S32, Axon Partners Group, OrbiMed, Cormorant Asset Management, Lifeforce Capital, Kite, a Gilead Company
$115M2025-11-20Aspen NeuroscienceARCH Venture Partners, S32, Axon Partners Group, Cormorant Asset Management, Lifeforce Capital, Avon Ventures, Kite, a Gilead Company, Section 32
$71M2024-06-04VilyaARCH Venture Partners, Menlo Ventures, Madrona Venture Group, Altitude Life Science Ventures, Lifeforce Capital
$71M2024-06-04Vilya TherapeuticsARCH Venture Partners, Menlo Ventures, NVentures, Madrona Venture Group, Altitude Life Science Ventures, Lifeforce Capital
$30M2022-10-19Ochre BioKhosla Ventures, BACKED VC, Y Combinator, Lifeforce Capital
$50M2022-06-02Transition BioNorthpond Ventures, Taiho Ventures, Bristol Myers Squibb, Cambridge Enterprise, Lifeforce Capital, Magnetic Ventures
$147M2022-05-09Aspen NeuroscienceARCH Venture Partners, Mirae Asset, EDBI, Alexandria Venture Investments, S32, Lifeforce Capital
$265M2021-08-04Sonoma BiotherapeuticsARCH Venture Partners, 8VC, Casdin Capital, Mirae Asset, Lifeforce Capital, Vertex Ventures HC, Osage University Partners
$—2020-11-30Transition BioLifeforce Capital